Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia

Blood Adv (2020) 4 (19): 4918–4923.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals